Skip to main content
Top

[18F]NaF PET/CT Imaging of Iliac Bones to Assess Bone Turnover

Published in:

Abstract

Purpose

This study investigated the effects of laterality, age, gender, BMI, and physical activity level on iliac bone turnover using [18F]NaF PET/CT.

Procedures

Fifty-nine males and 44 females from the CAMONA study were analyzed. A region of interest (ROI) was drawn to segment the iliac bone using Hounsfield unit thresholds and morphological closing algorithm. [18F]NaF SUVmean was compared between the left and right iliac bones using a paired t-test, while Pearson correlation coefficient assessed changes with age, BMI, and physical activity level.

Results

[18F]NaF uptake was higher in right iliac bone than left in males, females, and the combined-group. In males, SUVmean was 2.98 ± 1.63 (1.1–7.87) on left and 3.71 ± 1.49 (1.49–3.7) on right. In females, SUVmean was 2.59 ± 1.14 (0.88–6.27) on left and 3.72 ± 1.04 (2.22–6.51) on right. Combined, SUVmean was 2.81 ± 1.44 (0.88–7.87) on left and 3.71 ± 1.31 (0.89–8.07) on right. [18F]NaF uptake negatively correlated with age (right: r = - 0.27, P = 0.006; left: r = - 0.22, P = 0.02), stronger in females (right: r = - 0.30, P = 0.04; left: r = - 0.31, P = 0.04) than males (right: r = - 0.26, P = 0.04; left: r = - 0.18, P = 0.18). SUVmean correlated positively with BMI in males (right: r = 0.47, P = 0.0002; left: r = 0.38, P = 0.0027), females (right: r = 0.36, P = 0.0168; left: r = 0.30, P = 0.0505), and combined-group (right: r = 0.43, P < 0.0001; left: r = 0.37, P = 0.0001). No significant correlation was found between SUVmean and physical activity in males, while in females, a negative correlation was observed on left (r = - 0.37, P = 0.0390) but not on right (r = - 0.27, P = 0.1302), and when combined, the correlation remained significant on left (r = - 0.24, P = 0.0372) but not on right (r = - 0.16, P = 0.1541).

Conclusions

[18F]NaF uptake was higher in the right iliac bone and declined with age, particularly in females. The positive correlation between SUVmean and BMI; and the negative correlation between SUVmean and physical activity suggest metabolic influences on bone turnover. [18F]NaF PET/CT may serve as a tool for assessing bone metabolism and turnover in asymptomatic individuals.
Title
[18F]NaF PET/CT Imaging of Iliac Bones to Assess Bone Turnover
Authors
Shashi B. Singh
Om H. Gandhi
Bimash B. Shrestha
Patrick Glennan
Anuradha Rosario Bahadur
Niloofaralsadat Motamedi
Kishor Khanal
Sagar Wagle
Poul Flemming Høilund-Carlsen
Thomas J. Werner
Mona-Elisabeth Revheim
Abass Alavi
Publication date
24-04-2025
Publisher
Springer International Publishing
Published in
Molecular Imaging and Biology / Issue 3/2025
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-025-02003-6
This content is only visible if you are logged in and have the appropriate permissions.

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

1.75 AMA PRA Category 1 Credits

Explore using biomarker testing to interpret results and guide treatment strategies through an interactive patient simulation and unique educational escape rooms.

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Lilly
Learn more TODO (Link opens in a new window)

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Lilly
Learn more TODO (Link opens in a new window)
Image Credits
Alzheimer’s disease in the biomarker era: preparing the multidisciplinary care team/© Springer Healthcare IME, Navigating neuroimaging in Alzheimer’s care: Practical applications and strategies for integration/© Springer Health+ IME